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Abstract 
Background: Type B aortic dissection (TBAD) estimated annual incidence is between 
2.9 and 4.0 per 100,000. DISSECT classification aims to reunite clinical and anatomical 
characteristics of interest to clinicians involved in its management. The aim of this paper 
is to describe the reality of a tertiary institution with a referral area of 0.7 million 
inhabitants.  
 
Methods: This is a retrospective study that included all patients with TBAD admitted to 
hospital from march 2006 to the end of 2016. The computerized tomographic 
angiography that enabled the TBAD diagnosis was classified using DISSECT 
classification. 
 
Results: Thirty-two patients were included, setting up a TBAD incidence of 
approximately 0.6 per 100,000 per year. As to DISSECT classification, 79.3% were acute 
(Duration), 66% had a primary Intimal tear location in aortic arch, the maximum trans-
aortic diameter was 44±13mm (Size), 60% extended from aortic arch to abdomen or iliac 
arteries (Segmental Extent), 28% presented with Complications, and 28% had partial 
Thrombosis of false lumen. Six patients underwent surgery. At 12 months, overall 
survival was 67.2%±9.1% and survival free of aorta-related mortality was 74±8.9%. 
Survival free of aortic dilatation was 54.4±10.3%. In univariate analysis, the presence of 
complications and chronic kidney disease associated with increased overall and aorta-
related mortality rates. Hypertension was associated with aortic dilatation.  
 
Conclusions: The incidence verified was lower than what has been described in literature. 
DISSECT classification can be easily applied to TBAD cases. The presence of 
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complications, chronic kidney disease and hypertension were identified as prognostic 
determinants. 
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Introduction 
Type B aortic dissection (TBAD) consists on a tear of the aorta inner lining of aorta, 
causing the presence of a false lumen that allows blood circulation on the media layer[1]. 
Standford classification divides this pathology, based on anatomic criteria, in type A 
aortic dissection, which involves the ascending aorta, and TBAD, which originates 
distally to the left subclavian artery, thus involving the descending aorta[2]. TBAD 
corresponds to 40% of all aortic dissections and has an estimated incidence between 2.9 
and 3.5 per 100000. This condition is associated with high morbidity and mortality[3-5]. 
It affects mostly men between the ages of 60 and 65 [1, 6]. The classic presentation 
consists in sudden and intense chest and interscapular pain associated with 
hypertension[3, 7]. In fact, although the etiology of TBAD is multifactorial, hypertension 
is an important risk factor and it can be found in 80% of cases [1, 8]. The clinical 
management of this patients has been highly controversial mainly since the development 
of endovascular techniques that allow the repair of the dissected aorta in a less invasive 
way than open surgery [9]. The patients with complicated TBAD (malperfusion 
syndrome, aortic rupture, aneurismal dilatation, proximal or distal progression of the 
dissection, refractory pain and refractory hypertension) – about 20%, were classically 
treated with thoracotomy. However, European Society of Cardiology now recommends 
primary treatment with endovascular approach [1, 5, 10]. The new guidelines of European 
Society for Vascular Surgery also recommend this approach [7].  
The management of uncomplicated TBAD is more complex. The classic treatment 
consists on pharmacologic management with antihypertensive drugs, being beta-blockers 
the first line choice[6, 8]. However, the advance of thoracic endovascular aortic repair 
(TEVAR) has motivated its use as an alternative to the treatment of uncomplicated 
TBAD. There are two randomized trials that evaluate the possibility of using 
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endovascular methods as first line therapy: the INSTEAD-XL (Investigation of Stent 
Grafts in Aortic Dissection with extended follow-up) trial concluded that TEVAR in 
addition to best medical treatment allowed a 5-year improvement in aorta-related 
mortality [10]; the ADSORB (Acute Dissection Stentgraft OR Best Medical Treatment) 
trial [11] demonstrated, after a year of follow up, that TEVAR in addition to best medical 
treatment, is safe and is related with aortic remodeling, false lumen thrombosis and 
reduction of its diameter when compared with best medical treatment alone[11].  
The natural history of uncomplicated TBAD and, especially, the benefit of a more 
interventive strategy is yet to be clarified. Thus, the evaluation of patients with TBAD 
treated with the different available modalities is needed.  
The aim of this paper is to characterize the cohort of all patients admitted for type B aortic 
dissection in a tertiary institution. This will enable the evaluation of the incidence of the 
disease and verify if it follows what is described in the literature. 
 
Methods 
This paper consists on a retrospective study that included all patients with TBAD admitted 
on Centro Hospitalar de São João, with a referral area of about 0.7 million habitants, in 
the period from march of 2006 to the end of 2016. 
The sample was obtained from the analysis of all patients codified with aortic dissection 
in ICD10 (4441 – Aneurysm and Aortic Dissection; 44100 - Aortic Dissecting Aneurysm, 
site non-specified; 44101 – Thoracic Aortic Dissecting Aneurysm; 44102 – Abdominal 
Aortic Dissecting Aneurysm; 44103 – Thoraco-abdominal Aortic Dissecting Aneurysm). 
Demographic characteristics, comorbidities such as diabetes, hypertension, 
hyperlipidemia, carotid disease, coronary disease, chronic kidney disease, pulmonary 
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disease, heart failure, history of coronary treatment (percutaneous transluminal coronary 
angioplasty and coronary artery bypass surgery), peripheral artery disease, history of 
heart surgery and usual medication of all patients were collected from clinical registries. 
For each patient, the computerized tomographic (CT) angiography that enabled the 
TBAD diagnosis was classified using the DISSECT classification. The date of this CT 
scan was considered the inclusion date of these patients. The DISSECT classification, 
proposed by M.D.Dake[12], is a new mnemonic based approach on the evaluation of 
aortic dissections that aims at standardizing the imaging and clinical classification of this 
patients. This classification includes the analysis of six variables that influence the 
therapeutic decision Duration of dissection, (primary) Intimal tear location within the 
aorta, Size based on the maximum trans-aortic diameter (true lumen), aortic involvement 
Segmental extent from proximal to distal boundary, Clinical complications related to 
dissection and aortic false lumen Thrombosis. 
The primary outcomes of this paper were defined as overall mortality, aorta-related 
mortality and aortic dilatation. The need for aortic surgery after TBAD diagnosis was also 
analyzed. 
The statistical analyses were performed using SPSS software. Continuous variables were 
expressed as mean ± standard deviation (SD) when normally distributed and as median 
and interquartile range (IQR) when skewed. Categorical variables were presented as 
percentages. Overall mortality rates and aorta-related mortality rates were estimated using 
Kaplan-Meier method. Mantel-Cox analyses was used to study determinants of mortality 
and aortic dilatation. 
 
Funds 
No funds were required to perform this analyzes. 
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Results 
We included 32 patients, ascertaining a TBAD incidence of approximately 0.6 per 100000 
in the last 10 years. Demographic and clinical characteristics of this patients are showed 
in Table 1.  The majority were men (84%) with a mean age of 60±13 years; 84% were 
hypertense, 46% were ex-smokers or active smokers and 13% had diabetes.  
DISSECT classification 
As to DISSECT classification, 79.3% were acute (Duration), 66% had an Intimal tear 
(primary) location in the aortic arch, the maximum trans-aortic diameter was 44±13mm 
(Size), 60% extended from aortic arch to abdomen or iliac arteries (Segmental extent), 
28% presented with Complications, being rupture and branch vessel malperfusion the 
most frequent, and 28% had partial false lumen Thrombosis (versus 66% with 
permeability of false lumen). DISSECT classification is represented in table 2.  
Aortic Intervention 
Six patients underwent surgery, 3 of them in acute phase, 1 of them in subacute phase and 
2 of them in chronic phase. All patients that underwent surgery in acute and subacute 
phase did so due to complications of TBAD, being either branch vessel malperfusion (1 
of them) or aortic rupture (3 of them). The reasons for aortic intervention and respective 
procedure are specified in Table 3. 
Mortality 
At 12 months, overall survival of this series was 67.2%±9.1% and survival free of aorta-
related mortality was 74.4±8.9% (Figure 1 A and B). Mortality causes are reported in 
table 4. At 12 months, survival free of aortic dilatation was 54.4±10.3% (Figure 1 C). 
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Table 4 discriminates the causes of mortality of each patient and the time between the 
inclusion and death of each of them. 
Mantel-Cox analyses identified the presence of complications and chronic kidney disease 
as risk factors of overall mortality and aorta-related mortality. Hypertension was 
identified as a risk factor of aortic dilatation. No significant differences were found in the 
remaining groups. Univariate analyses for predictors of overall mortality, aorta-related 
mortality and aortic dilatation are showed in Table 5. 
 
Discussion 
The verified incidence of TBAD was lower that what has been reported in literature (0.6 
per 100000 vs 2.5 to 3.9 per 100000)[3]. The sample was obtained from the analyses of 
the patients codified with dissection and patients codified with aortic aneurismal disease. 
There is no codification that corresponds directly to patients with TBAD. Therefore, a 
possible explanation for this low incidence of the disease may be the miscoding of 
patients with this pathology. In addition, an elevated number of the patients analyzed on 
preliminary phase did not presented with CT scan and, therefore, were not included in 
this study since this diagnose could not be confirmed. This may explain a possible sub 
representation of patients with TBAD in this sample. The low incidence may also reflect 
less disease in the population studied. 
The CT scans of this patients were evaluated with DISSECT classification. Classically, 
two classifications based mostly on anatomic characteristics were used, DeBakey 
classification [13], proposed in 1965, and Stanford classification[2], proposed in 1970. 
Both of these methods are based in aorta imaging and allow the division of the patients 
in two groups: those who will benefit from surgical treatment and those who will be 
submitted to medical treatment alone. However, these classifications do not consider the 
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current guidelines for the treatment of TBAD, in which endovascular techniques may play 
an important role. In this decision, factors such as duration of the disease, presence of 
complications or false lumen thrombosis need to be considered and the previously 
referred classic methods do not take them in to account. Therefore, the DISSECT 
classification, proposed by M.D. Dake and published in 2013, a mnemonic based method, 
is easy to apply and takes into consideration a group of characteristics of interest in 
contemporary therapeutic decision of patients with aortic dissection, particularly those 
with TBAD. This classification allows an easy interaction between anatomical and 
clinical aspects that are relevant to assist the decision of contemporary treatment of 
patients with TBAD, in which endovascular techniques are emerging [12].  
Our univariate analyses showed the presence of complications and chronic kidney disease 
as risk factors of overall mortality and aorta-related mortality. Hypertension was 
identified as a risk factor of aortic dilatation. Some independent risk factors for mortality 
in TBAD has been described in literature (Table 6), such as age and some other clinicals 
co-morbidities, as acute renal failure, coronary heart disease or pulmonary disease as 
independent predictors of mortality [4, 14-20]. 
The classic treatment for non-complicated TBAD consists on pharmacologic managing 
with antihypertensive drugs, being beta-blockers the first line choice as the best medical 
treatment[14], but the overall survival of the patients treated with the best medical 
treatment can be as low as 50%, at 5 years,[11] and the estimated rate of rupture is about 
56% when aortic lumen is over 60mm, also at 5 years[21]. New trends in the treatment 
of patients with TBAD show endovascular techniques as an option for the treatment of 
these patients. There are two randomized trials that compares the two therapeutic options.  
Nienaber et al., in INSTEAD-XL trial [10], randomized 72 for treatment with TEVAR 
plus best medical treatment and 68 patients for best medical treatment alone. The results 
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showed that TEVAR is associated to a lower aortic related mortality at 5 years follow-up 
(6.9±3.0% with TEVAR, and 19.3±4.8% with best medical treatment). Furthermore, 
TEVAR was associated with a greater expansion of the true lumen and greater decrease 
in false lumen when compared with medical treatment alone and complete false lumen 
thrombosis was found in 90.6% of the patients. On the other hand, with medical treatment 
the false lumen thrombosis was only 22% and aortic expansion was seen in 66% of the 
patients (vs 20.8% with TEVAR). 
As in INSTEAD-XL, Brunkwall et al., in the ADSORB trial [11] randomized 30 patients 
for treatment with TEVAR and 31 for best medical treatment alone. They also verified a 
greater expansion of true lumen and greater decrease of false lumen with TEVAR rather 
than with best medical treatment alone. Moreover, false lumen thrombosis was not found 
in 97% of the patients with medical treatment vs 13% with TEVAR. Thereby, these trials 
show benefit in the use of endovascular treatment with decreased mortality due to 
beneficial effects on aortic remodeling and thrombosis in the false lumen. In this study, 
however, none of the patients with non-complicated TBAD were submitted to 
endovascular treatment. 
Other studies have been carried to evaluate prognosis determinants in non-complicated 
TBAD to, perhaps, determinate the patients that would benefit from an endovascular 
procedure as first line therapy. Schwartz et al, evaluated 254 patients with medical 
treatment and concluded that an aortic diameter >40mm, an entry tear >10mm and 
patency of true lumen are associated with an increased risk of subsequent aortic 
intervention and recommend treatment with TEVAR in these cases [22]. Also, a false 
lumen >22mm and an aortic diameter >44mm are predictors of intervention [18]. A new 
study, conducted by Sailer et al[23], demonstrates that the presence of connective tissue 
disease and 4 morphological features identified by CT scan (false lumen circumferential 
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coverage, maximum aortic diameter, false lumen outflow volume and number of 
intercostals arteries) are associated with late adverse events. Thereby, they developed a 
risk-prediction internally validated model that allows to calculate the individual risk of 
adverse events after an initially uncomplicated TBAD, identifying patients who would 
benefit of an endovascular intervention at an early stage. Thus, recent literature suggests 
that uncomplicated TBAD treated with TEVAR is associated with lower aortic 
remodeling and lower mortality, promoting its use, especially in patients that have 
predictors of later intervention or adverse prognosis. 
 
 
Conclusion 
TBAD is an entity whose best approach to patients is yet to be clarified. DISSECT 
classification can help in decision making of the treatment of these patients. New trends 
in the treatment of patients with TBAD show endovascular techniques as a viable option 
for their treatment, especially in those which clinical and anatomic characteristics predicts 
later intervention. Notwithstanding, further studies are needed to characterize TBAD in 
Portugal. 
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Table 1 - Demographic characteristics and comorbidities of 32 patients with type B aortic dissection. 
 No. or mean % 
Gender 
Male 
Female 
 
27 
5 
 
84.4 
15.6 
Age 60.34±12.69  
Tobaco 
No 
Ex-smoker 
Smoker 
 
14 
5 
7 
 
53.8 
19.2 
26.9 
Diabetes Mellitus 
No 
Diet or oral medication controlled 
Insulin dependent 
 
 
28 
13 
1 
 
87.5 
9.4 
3.1 
Hyperthension 
No 
Regulated by monotherapy 
Regulated by 2 drugs 
Regulated by > 2 drugs 
 
5 
25 
2 
0 
 
 
15.6 
78.1 
6.3 
0.0 
Carotid disease 
No 
Assymtomatic significant stenosis 
History of transient ischemic attack 
Ischemic stroke 
 
 
28 
0 
1 
3 
 
87.5 
0.0 
3.1 
9.4 
Cornorary disease 
No  
Stable Angina    
Unstable Angina    
MI > 1 year   
MI <1 year  
 
29 
0 
0 
0 
3 
 
90.6 
0.0 
0.0 
0.0 
9.4 
Chronic kidney disease 
No  
Mild increased serum creatinine <210μmol/L
    
Severe increased serum creatinine 220-
250μmol/L   
Serum creatinine >250μmol/L or 
dialysis/kidney transplantation dependent) 
 
21 
7 
 
2 
 
2 
 
 
65.6 
21.9 
 
6.3 
 
6.3 
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Table 2 – Complications in type B aortic dissection patients. 
 No. or mean % 
Duration 
Acute - < 2 weeks from onset of symptoms 
Subacute - 2 weeks to 3 months after symptom onset 
Chronic - > 3 months from initial symptoms 
 
23 
1 
5 
 
79.3 
3.4 
17.2 
Intimal tear location 
Ascending aorta 
Aortic arch 
Descending aorta 
Abdominal aorta 
Unknwon 
 
0 
21 
11 
0 
0 
 
0.0 
65.6 
34.4 
0.0 
0.0 
Aortic size 
maximum trans-aortic diameter 
22.69±10.81 
43.73±13.24 
 
 
Segmental extent 
Aortic Arch to Abdominal Aorta   
Aortic Arch to Iliac 
Descending exclusively  
Descending to abdominal Aorta 
Descending to iliac 
 
10 
11 
5 
1 
5 
 
30.3 
33.3 
15.2 
3.0 
15.2 
Complications 
Aortic valve involvement 
Cardiac tamponade  
Rupture   
Branch vessel malperfusion   
Progression of aortic involvement with proximal or distal 
extension of dissection   
Other   
None 
 
0 
1 
5 
3 
0 
 
0 
23 
 
0.0 
3.1 
15.6 
9.4 
0.0 
 
0.0 
71.9 
False lumen thrombosis 
Patent aortic false lumen 
Complete thrombosis 
False thrombosis 
 
21 
2 
9 
 
65.6 
6.3 
28.1 
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Table 3 - Reasons for aortic intervention and respective procedure. 
Time between inclusion and aortic 
surgery 
Reason for intervention Type of aortic intervention 
2 days Branch vessel malperfusion TEVAR 
6 days Aortic rupture TEVAR 
9 days Aortic rupture TEVAR 
18 days Aortic rupture 
Intra-abdominal vascular shunt 
or bypass 
1173 days 
Aortic valve insufficiency and 
ascending aorta aneurysm 
Aortic valvuloplasty 
2511 days Abdominal aorta aneurysm TEVAR 
 
 
 
 
Table 4 - Causes of mortality in patients with type B aortic dissection. 
Time between inclusion and death Cause of death 
1 day Ventricular fibrillation 
8 days Aortic rupture  
10 days Aortic rupture  
13 days Aortic rupture  
21 days Aortic rupture  
50 days Aortic rupture 
344 Intracerebral hemorrhage 
513 days Septic shock 
965 days Aortic rupture 
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Table 5 - Univariate analyses for predictors of overall mortality, aorta-related mortality and aortic dilatation. 
 
Overall mortality 
(P-value) 
Aorta-related mortality 
(P-value) 
Aortic dilatation 
(P-value) 
Male gender 0.546 0.546 0.179 
Smoker 0.899 0.384 0.728 
Diabetes 0.500 0.750 0.210 
Hypertension 0.585 0.186 <0.001 
Carotid disease 0.575 0.110 0.072 
Coronary disease 0.835 0.406 0.637 
Chronic Kidney 
disease 
0.002 0.002 0.454 
Heart failure 0.749 0.515 0.391 
Peripheral arterial 
disease 
0.240 0.703 0.690 
Duration of 
presentation 
0.046 0.052 0.469 
Intimal tear 
location 
0.276 0.045 0.768 
Complications <0.001 <0.001 0.052 
False lumen 
thrombosis 
0.399 0.255 0.955 
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Table 6 - Predictors of mortality in type B aortic dissection. 
Glower, 1990 [14] Presenting complication of dissection 
Age 
Rupture 
Umaña, 2002 [15] Shock  
Visceral ischemia 
Arch extension 
Rupture  
Stroke  
Previous sternotomy  
Coronary artery disease 
Pulmonary disease 
Suzuki, 2003 [16] Branch vessel involvement 
Lack of chest/back pain 
Hypotension/shock 
Tsai, 2006 [17] Female gender 
History of prior aortic aneurysm 
History of atherosclerosis 
In-hospital renal failure 
Pleural effusion on chest radiograph 
In-hospital hypotension/shock 
Jonker, 2013 [4] Age ≥ 70 years 
Descending aortic diameter ≥ 5.5 cm 
Hypotension/shock 
Visceral ischemia 
Acute renal failure 
Ray, 2016 [18] Aortic diameter >44 mm 
Age>60 years 
Matsushita, 2017[19] Initial aortic diameter >40mm 
False-lumen diameter > true-lumen diameter 
Guo, 2017 [20] Maximum diameter of the affected aorta 
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Figures Legend 
Figure 1 - Overall survival (A), survival free of aorta-related mortality (B) and survival 
free of aortic dilatation of 32 patients with TBAD (C) at 12 months. 
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APÊNDICES 
Introduction
Type B aortic dissection (TBAD) affects mostly men with an estimated annual incidence between 2.9 and 3.9 per 100,000, appeared to be increasing [1]. DISSECT classification was
published in 2013 aiming to reunite clinical and anatomical characteristics of interest to clinicians involved in TBAD management [2]. The clinical management of this patients has been highly
controversial, mainly since the development of endovascular techniques. In Portugal, the incidence of the condition, as well as its characteristics and outcomes, are not well documented. The
aim of this paper is to describe the reality of a tertiary institution with a referral area of about 0.6 millions habitants.
Predictors of prognosis in patients with type B aortic
dissection
Authors: Marina Dias-Neto, Isabel Poleri, Sérgio Sampaio
Institutions: Department of Angiology and Vascular Surgery, São João Hospital, Porto, Portugal; Faculty of Medicine, University of Porto, Portugal.
Methods
This is a retrospective study that included all patients with TBAD admitted at São João
Hospital Center from 2008 to 2016. The patients were categorized according to their
demographic and clinical characteristics collected from clinical registries. For each patient,
the computerized tomographic angiography (CTA) scan that enabled the TBAD diagnosis
was classified using DISSECT classification [2].
The statistical analyses were performed using SPSS software. Continuous demographic
variables were expressed as mean ± standard deviation if they had normal distribution or
not, respectively. Categorical variables were presented as percentages. Overall mortality
rates and aorta-related mortality rates were estimated using Kaplan-Meier method. Cox
regression was used to study determinants of mortality.
Discussion
The verified incidence of TBAD was lower that what has been reported in literature (0.6
per 100,000 vs 2.5 to 3.9 per 100000) [3].
- The sample was obtained from the analysis of the hospital admissions coded with
dissection and/or aortic aneurismal disease since there is no codification that
corresponds directly patients with TBAD. Therefore, a possible explanation for this low
incidence of the disease may be the existence of coding errors of patients with this
pathology.
- In addition, an elevated number of the patients analyzed on preliminary phase did not
presented with CT scan so they were excluded from this study. This may explain a
possible sub representation of patients with TBAD in this sample.
- This low incidence may also be a reflection of lower burden of this disease in the studied
population.
The CT scans of this patients were evaluated with DISSECT classification.
- DeBakey classification [4] and Stanford classification[5] are classifications of aortic
dissection based in aorta imaging, allowing the division of the patients in those who will
benefit from surgical treatment or medical treatment alone. These classifications do not
consider the current guidelines for the treatment of this patients, in which endovascular
techniques play an important role.
- DISSECT classification, proposed by M.D. Dake and published in 2013, a mnemonic
based method, is easy to apply and allows an interaction between anatomical and
clinical aspects that are relevant to assist the decision of contemporary treatment of
patients with TBAD, in which endovascular techniques are emerging [2].
As for predictors of mortality, this study found that the presence of complications is an
independent risk factor of overall mortality.
- This agrees with what has been described in literature.
- Apart from complications, some studies also showed age and some other clinicals co-
morbidities such as acute renal failure, coronary heart disease or pulmonary disease as
predictors of mortality (4 and 16), Table 2. However, this was not found in our study.
Results
Demographic and clinical features
We included 32 patients, setting up a TBAD incidence of approximately 0.6 per 100,000 in
the last 8 years. The majority were men (83%) with a mean age of 60±12 years-old; 71%
were hypertense, 56% were ex-smokers or active smokers and 13% had diabetes.
DISSECT classification
Já a disposição de imagens vai depender sempre do destaque que o autor lhes queira
atribuir. Podem ter a largura de uma coluna, metade da mesma ou a largura útil total da
página.
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 No. or mean % 
Duration 
Acute - < 2 weeks from onset of symptoms 
Subacute - 2 weeks to 3 months after symptom 
onset 
Chronic - > 3 months from initial symptoms 
 
22 
1 
5 
 
78,6 
3,6 
17,9 
Intimal tear location 
Ascending aorta 
Aortic arch 
Descending aorta 
Abdominal aorta 
Unknwon 
 
0 
21 
11 
0 
0 
 
0,0 
65,6 
34,4 
0,0 
0,0 
Aortic size 
maximum trans-aortic diameter 
22,69±10,81 
43,73±13,24 
 
 
Segmental extent 
Aortic to Abdominal   
Aortic to Iliac 
Descending exclusively 
Descending to abdominal 
Descending to iliac 
 
1 
10 
11 
5 
1 
5 
 
3,0 
30,3 
33,3 
15,2 
3,0 
15,2 
Complications 
Aortic valve involvement 
Cardiac tamponade  
Rupture   
Branch vessel malperfusion   
Progression of aortic involvement with proximal 
or distal extension of dissection   
Other   
None 
 
0 
1 
4 
3 
0 
 
0 
24 
 
0,0 
3,1 
12,5 
9,4 
0,0 
 
0,0 
75,0 
False lumen thrombosis 
Patent aortic false lumen 
Complete thrombosis 
False thrombosis 
 
25 
2 
9 
 
65.6 
6,3 
28,1 
	
Table 1- Characteristics of the patients in DISSECT classification.
Aortic intervention
Seven patients underwent surgery, 4 of them in acute phase, 1 in subacute phase and 2 in
chronic phase. All patients that underwent surgery in acute and subacute phase were due
complications of TBAD, that included branch vessel malperfusion (1 of them) or aortic
rupture (4 of them). The patients were submitted to aortic surgery in chronic phase
presented aortic dilatation.
Mortality
At 12 months, overall survival of this series was 65,2%±9,0% and survival free from aorta-
related mortality was 83±6,7% (Figure 1 A and B). The presence of complications was
identified as an independent risk factor of overall mortality. This was not true to aorta-
related mortality.
Figure 1 A and B – Overall survival and survival free of aorta related mortality.
The classic treatment for non-complicated TBAD consists on pharmacologic managing with
antihypertensive drugs, being beta-blockers the first line choice as the best medical
treatment 6. However, new trends in the treatment of patients with TBAD show
endovascular techniques as an option for the treatment of this patients. ADSORB trial [13]
and INSTEAD-XL trial [14] show benefit in the use of endovascular treatment with
decreased mortality due to beneficial effects on aortic remodeling and thrombosis in the
false lumen. In this study, however, none of the patients with non-complicated TBAD
were submitted to endovascular treatment.
Conclusion
TBAD is an entity whose best approach to patients is yet to be clarified. DISSECT
classification can help in the decision of the treatment of these patients. Further studies are
needed to characterize TBAD in Portugal.
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Table 2 - Predictors of mortality in type b aortic dissection.
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